WallStreetZenWallStreetZen
Analyst Ranking
Bottom 5%
#4353 out of 4565 analysts
Average Return
-30.87%
Win Rate
20%7 out of 35
Risk vs Reward
Poor
Good

Roanna Ruiz's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cytokinetics IncCYTK
+98.10%$32.71$64.80
2023-08-14 -
2024-04-25
Buy
Xeris Biopharma Holdings IncXERS
+97.62%$1.26$2.49
2023-01-26 -
2024-01-26
Buy
Myovant Sciences LtdMYOV
+60.19%$16.68$26.72
2022-08-08 -
2022-10-25
Buy
Lantheus Holdings IncLNTH
+25.00%$70.08$87.60
2022-06-05 -
2023-06-05
Buy
Scpharmaceuticals IncSCPH
+18.39%$5.60$6.63
2022-10-10 -
2023-10-10
Buy

Roanna Ruiz Analyst Color

Get additional color on Roanna Ruiz's coverage of popular stocks

Roanna Ruiz's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ardelyx IncARDX
1Buy$14.00+121.87%Initiates Coverage On
21 days ago
Ars Pharmaceuticals IncSPRY
2Buy$18.00+122.50%Upgrades
2 months ago
United Therapeutics CorpUTHR
1Buy$330.00+39.86%Initiates Coverage On
3 months ago
Cytokinetics IncCYTK
1Buy$58.00-10.49%Initiates Coverage On
8 months ago
Corcept Therapeutics IncCORT
1Hold$25.00N/AInitiates Coverage On
a year ago
Pardes Biosciences IncPRDS
4Hold$2.00N/ADowngrades
a year ago
Enanta Pharmaceuticals IncENTA
10Hold$49.00N/AReiterates
a year ago
Xeris Biopharma Holdings IncXERS
4Buy$5.00N/AMaintains
a year ago
Vir Biotechnology IncVIR
3Buy$43.00N/AMaintains
a year ago
Scpharmaceuticals IncSCPH
5Buy$13.00N/AMaintains
a year ago
Atea Pharmaceuticals IncAVIR
6Hold$6.00N/AMaintains
a year ago
Newamsterdam Pharma Co NvNAMS
1Buy$19.00N/AInitiates Coverage On
a year ago
Lantheus Holdings IncLNTH
3Buy$120.00N/AMaintains
a year ago
Aligos Therapeutics IncALGS
7Hold$2.00N/AMaintains
a year ago
Myovant Sciences LtdMYOV
7Hold$27.00N/ADowngrades
2 years ago
Amarin Corp PLCAMRN
5Hold$2.00N/AMaintains
2 years ago
Contrafect CorpCFRXQ
3Hold$80.00N/ADowngrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.